Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Maceron Jul 31, 2019 12:21pm
99 Views
Post# 29979988

RE:RE:RE:TLT CURES CANCER

RE:RE:RE:TLT CURES CANCER
jicoop wrote: Agree, it's a little premature to use the 'C' word, and even if this proves out over time, it will probably still not be accurate to use the term CURE for some time, probably not even in my lifetime.
I knew a woman who was 'Cured' , or so they thought, but was in remission for over 30 years with Melanoma, but it came back and finished her off in 14 months time, so even that one sample could not be called a CURE .
If patient 6 comes back clear after 1.5 years, then statistically we are onto something BIG , but not the C word just yet, or ever.
Coop


regardless of cancer type and outcome from treatment. Even people that are cured are known to have a much shorter life expectancy. In the neighborhood of 5 years less. Significant.

BUt I will go out on a very sturdy limb and say that TLD 1433 will show CR in a very large number of patients with NMIBC. And there may even be an interesting twist with immune response secondary to repeat dosing.
Macer

Bullboard Posts